Targeting novel signaling pathways for resistant acute myeloid leukemia

被引：58

作者：

Sakamoto, Kathleen M. ^{[1
]}

Grant, Steven ^{[2
]}

Saleiro, Diana ^{[3
,4
]}

Crispino, John D. ^{[3
,4
]}

Hijiya, Nobuko ^{[6
]}

Giles, Francis ^{[3
,4
]}

Platanias, Leonidas ^{[3
,4
,5
]}

Eklund, Elizabeth A. ^{[3
,4
,5
]}

机构：

[1] Stanford Univ, Dept Pediat, Sch Med, Div Hematol Oncol, Stanford, CA 94305 USA

[2] Virginia Commonwealth Univ, Dept Med, Sch Med, Div Hematol Oncol & Palliat Care, Richmond, VA 23298 USA

[3] Northwestern Univ, Med Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA

[4] Northwestern Univ, Dept Med, Med Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA

[5] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA

[6] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2015年 / 114卷 / 03期

关键词：

Acute myeloid leukemia; Signaling pathways; Novel therapies; Resistance; ELEMENT-BINDING-PROTEIN; UBIQUITIN LIGASE TRIAD1; GENE-EXPRESSION; TYROSINE-PHOSPHATASE; ENCODING GP91(PHOX); BCL-2; INHIBITION; CLONAL EVOLUTION; DUAL INHIBITION; JAK INHIBITORS; CREB;

D O I：

10.1016/j.ymgme.2014.11.017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute myeloid leukemia (AML) is a hematologic malignancy that is the most common type of acute leukemia diagnosed in adults and the second most common type in children. The overall survival is poor and treatment is associated with significant complications and even death. In addition, a significant number of patients will not respond to therapy or relapse. In this review, several new signaling proteins aberrantly regulated in AML are described, including CREB, Triad1, Bcl-2 family members, Stat3, and mTOR/MEK. Identifying more effective and less toxic agents will provide novel approaches to treat AML. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：397 / 402

页数：6

共 50 条

[11] Targeting regulated cell death pathways in acute myeloid leukemia
Garciaz, Sylvain
Miller, Thomas
Collette, Yves
Vey, Norbert
CANCER DRUG RESISTANCE, 2023, 6 (01) : 151 - 168
[12] Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia
Murray, Heather C.
Miller, Kasey
Brzozowski, Joshua S.
Kahl, Richard G. S.
Smith, Nathan D.
Humphrey, Sean J.
Dun, Matthew D.
Verrills, Nicole M.
MOLECULAR & CELLULAR PROTEOMICS, 2023, 22 (03)
[13] Targeting Antagonists of Retinoic Acid Signaling in Acute Myeloid Leukemia
Hasipek, Metis
Grabowski, Dale
Guan, Yihong
Phillips, James G.
Maciejewski, Jaroslaw P.
Carraway, Hetty E.
Jha, Babal K.
BLOOD, 2018, 132
[14] Targeting receptor tyrosine kinase signaling in acute myeloid leukemia
Doepfner, Kathrin T.
Boller, Danielle
Arcaro, Alexandre
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (03) : 215 - 230
[15] Targeting Wnt signaling in acute myeloid leukemia stem cells
Pepe, Felice
Bill, Marius
Papaioannou, Dimitrios
Karunasiri, Malith
Walker, Allison
Naumann, Eric
Snyder, Katiri
Ranganathan, Parvathi
Dorrance, Adrienne
Garzon, Ramiro
HAEMATOLOGICA, 2022, 107 (01) : 307 - 311
[16] Targeting signaling pathways in acute lymphoblastic leukemia: new insights
Harrison, Christine J.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 118 - 125
[17] Targeting acute myeloid leukemia stem cell signaling by natural products
Siveen, Kodappully Sivaraman
Uddin, Shahab
Mohammad, Ramzi M.
MOLECULAR CANCER, 2017, 16
[18] Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia
Sexauer, Amy N.
Tasian, Sarah K.
FRONTIERS IN PEDIATRICS, 2017, 5
[19] Targeting acute myeloid leukemia stem cell signaling by natural products
Kodappully Sivaraman Siveen
Shahab Uddin
Ramzi M. Mohammad
Molecular Cancer, 16
[20] Targeting non-canonical Wnt signaling in acute myeloid leukemia
de Boer, Jasper
Walf-Vorderwulbecke, Vanessa
Horton, Sarah J.
Williams, Owen
CANCER RESEARCH, 2013, 73 (08)

← 1 2 3 4 5 →